top of page
Cancer52 analysis on rare and less common cancer research spend
Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less common...
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...
bottom of page